Aplastic anemia secondary to propylthiouracil: A rare and life-threatening adverse effect
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155217752079
Abstract: Background Propylthiouracil has been in use for more than half a century for the treatment of hyperthyroidism. While it is largely known to cause agranulocytosis, its association with aplastic anemia is rarely heard of. Our… read more here.
Keywords: secondary propylthiouracil; aplastic anemia; propylthiouracil rare; propylthiouracil ... See more keywords